These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4946015)

  • 1. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).
    Gottlieb JA; Guarino AM; Call JB; Oliverio VT; Block JB
    Cancer Chemother Rep; 1970 Dec; 54(6):461-70. PubMed ID: 4946015
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of malignant melanoma with camptothecin (NSC-100880).
    Gottlieb JA; Luce JK
    Cancer Chemother Rep; 1972 Feb; 56(1):103-5. PubMed ID: 5030802
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
    Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
    [No Abstract]   [Full Text] [Related]  

  • 6. [A clinical study of N-nitrosomethylurea].
    Vermel' EM; Korman NP; Milonov BV; Evseenko LS; Orlova RS
    Vopr Onkol; 1970 May; 16(5):31-7. PubMed ID: 4915916
    [No Abstract]   [Full Text] [Related]  

  • 7. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD; Hurwitz BS
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial of acetylenic carbamate: 1,1-diphenyl-2-propynyl cyclohexanecarbamate (NSC-112682).
    Gailani S; Blais M
    Cancer Chemother Rep; 1970 Jun; 54(3):187-90. PubMed ID: 4334087
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
    Panettiere F; Coltman CA
    Cancer; 1971 Apr; 27(4):835-41. PubMed ID: 4929936
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary clinical trials of butocin (NSC-172755) in patients with generalized carcinoma of the breast.
    Andrysek O; Dienstbier Z; Semonský M; Zámecník J
    Cancer Chemother Rep; 1973; 57(3):311-8. PubMed ID: 4356396
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
    Weiss AJ; Wilson WL
    Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of hexamethylmelamine (NSC-13875) on small cell carcinoma of the lung (phase II study).
    Takita H; Didolkar MS
    Cancer Chemother Rep; 1974; 58(3):371-4. PubMed ID: 4601667
    [No Abstract]   [Full Text] [Related]  

  • 14. Postsurgical adjuvant chemotherapy: a review.
    Diekamp U; Lad TE; McGuire WP
    Surg Annu; 1981; 13():31-52. PubMed ID: 7025285
    [No Abstract]   [Full Text] [Related]  

  • 15. Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
    Slack NM; Jones R
    Cancer Chemother Rep; 1970 Feb; 54(1):53-63. PubMed ID: 4945998
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC; DeConti RC; Hubbard SP
    Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
    [No Abstract]   [Full Text] [Related]  

  • 17. An overview of the status of the nitrosoureas in other tumors.
    Carter SK
    Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
    [No Abstract]   [Full Text] [Related]  

  • 18. Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma.
    Hansen HH; Muggia FM; Andrews R; Selawry OS
    Cancer; 1972 Aug; 30(2):315-24. PubMed ID: 4559404
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).
    Luce JK; Thurman WG; Isaacs BL; Talley RW
    Cancer Chemother Rep; 1970 Apr; 54(2):119-24. PubMed ID: 4334086
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819).
    Muggia FM; Selawry OS; Hansen HH
    Cancer Chemother Rep; 1971 Dec; 55(5):575-81. PubMed ID: 4946082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.